| Cohance Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543064 |
NSE Symbol : COHANCE |
P/E(TTM) : 34.16 |
|
ISIN Demat : INE03QK01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 8.84 |
|
Book Value(₹) : 115.25 |
Market Cap(₹Cr) : 11,553.53 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 481.58 | 497.79 | 483.58 | 768.57 | 653.35 | 594.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 481.58 | 497.79 | 483.58 | 768.57 | 653.35 | 594.43 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.12 | 26.30 | 13.10 | 8.19 | 21.48 | 15.76 |
| Total Income | 487.70 | 524.09 | 496.68 | 776.76 | 674.83 | 610.19 |
| Total Expenditure | 383.66 | 366.93 | 387.48 | 561.58 | 420.60 | 390.91 |
| PBIDT | 104.04 | 157.16 | 109.20 | 215.18 | 254.23 | 219.28 |
| Interest | 5.25 | 5.24 | 6.80 | 7.00 | 10.08 | 9.42 |
| PBDT | 98.79 | 151.92 | 102.40 | 208.18 | 244.15 | 209.86 |
| Depreciation | 33.36 | 31.20 | 31.36 | 42.58 | 38.09 | 34.56 |
| Tax | 12.66 | 26.21 | 18.15 | 30.74 | 69.90 | 43.91 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.48 | 0.22 | 0.32 | 12.09 | -17.70 | -7.71 |
| Reported Profit After Tax | 47.29 | 94.29 | 52.57 | 122.77 | 153.86 | 139.10 |
| Extra-ordinary Items | -3.51 | 0.00 | -5.99 | -11.70 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 50.80 | 94.29 | 58.56 | 134.47 | 153.86 | 139.10 |
| EPS (Unit Curr.) | 1.24 | 2.46 | 1.38 | 3.22 | 4.04 | 3.65 |
| EPS (Adj) (Unit Curr.) | 1.24 | 2.46 | 1.38 | 3.22 | 4.04 | 3.65 |
| Calculated EPS (Unit Curr.) | 1.24 | 2.46 | 2.06 | 4.82 | 6.04 | 5.46 |
| Calculated EPS (Adj) (Unit Curr.) | 1.24 | 2.46 | 2.06 | 4.82 | 6.04 | 5.46 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.94 | 9.86 | 8.26 | 19.29 | 24.17 | 21.85 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.94 | 9.86 | 8.26 | 19.29 | 24.17 | 21.85 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 38.26 | 38.26 | 25.46 | 25.46 | 25.46 | 25.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.60 | 31.57 | 22.58 | 28.00 | 38.91 | 36.89 |
| PBDTM(%) | 20.51 | 30.52 | 21.18 | 27.09 | 37.37 | 35.30 |
| PATM(%) | 9.82 | 18.94 | 10.87 | 15.97 | 23.55 | 23.40 |
